Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults

作者: Jennifer N. Vega , Julie Dumas , Paul A. Newhouse

DOI: 10.1016/J.JAGP.2017.04.001

关键词:

摘要: Advances in cancer treatment are producing a growing number of survivors; therefore, issues surrounding quality life during and following have become increasingly important. Chemotherapy-related cognitive impairment (CRCI) is problem that commonly reported the administration chemotherapy patients with cancer. Research suggests CRCI can persist for months to years after completing treatment, which has implications trajectory normal pathologic aging long-term survivors. These problems particularly relevant older individuals, given largely disease age, who aged 65 or will increase dramatically over coming decades. This review briefly summarize empirical findings related CRCI, discuss cancer, propose potential causative hypotheses, provide canonical patient case illustrate how presents clinically. Finally, intervention strategies be highlighted consider when evaluating history discussed.

参考文章(125)
Kah Poh Loh, Michelle C. Janelsins, Supriya G. Mohile, Holly M. Holmes, Tina Hsu, Sharon K. Inouye, Meghan S. Karuturi, Gretchen G. Kimmick, Stuart M. Lichtman, Allison Magnuson, Mary I. Whitehead, Melisa L. Wong, Tim A. Ahles, Chemotherapy-related cognitive impairment in older patients with cancer Journal of Geriatric Oncology. ,vol. 7, pp. 270- 280 ,(2016) , 10.1016/J.JGO.2016.04.008
Allison Magnuson, Supriya Mohile, Michelle Janelsins, Cognition and Cognitive Impairment in Older Adults with Cancer. Current Geriatrics Reports. ,vol. 5, pp. 213- 219 ,(2016) , 10.1007/S13670-016-0182-9
Shirley M. Bluethmann, Angela B. Mariotto, Julia H. Rowland, Anticipating the “Silver Tsunami”: Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States Cancer Epidemiology, Biomarkers & Prevention. ,vol. 25, pp. 1029- 1036 ,(2016) , 10.1158/1055-9965.EPI-16-0133
Kevin T. Nead, Greg Gaskin, Cariad Chester, Samuel Swisher-McClure, Nicholas J. Leeper, Nigam H. Shah, Association Between Androgen Deprivation Therapy and Risk of Dementia. JAMA Oncology. ,vol. 3, pp. 49- 55 ,(2017) , 10.1001/JAMAONCOL.2016.3662
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin, Angela B. Mariotto, Joan L. Kramer, Julia H. Rowland, Kevin D. Stein, Rick Alteri, Ahmedin Jemal, Cancer treatment and survivorship statistics, 2016 CA: A Cancer Journal for Clinicians. ,vol. 66, pp. 271- 289 ,(2016) , 10.3322/CAAC.21349
Leonardo H Tonelli, Teodor T Postolache, Esther M Sternberg, Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior. Frontiers in Bioscience. ,vol. 10, pp. 675- ,(2005) , 10.2741/1562
J. A. Lawrence, L. Griffin, E. P. Balcueva, D. L. Groteluschen, T. A. Samuel, G. J. Lesser, M. J. Naughton, L. D. Case, E. G. Shaw, S. R. Rapp, A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy Journal of Cancer Survivorship. ,vol. 10, pp. 176- 184 ,(2016) , 10.1007/S11764-015-0463-X
Florence Joly, Bénédicte Giffard, Olivier Rigal, Michiel B. De Ruiter, Brent J. Small, Martine Dubois, Johan LeFel, Sanne B. Schagen, Tim A. Ahles, Jeffrey S. Wefel, Janette L. Vardy, Véronique Pancré, Marie Lange, Hélène Castel, Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012 Journal of Pain and Symptom Management. ,vol. 50, pp. 830- 841 ,(2015) , 10.1016/J.JPAINSYMMAN.2015.06.019
Tim A. Ahles, Brain vulnerability to chemotherapy toxicities Psycho-oncology. ,vol. 21, pp. 1141- 1148 ,(2012) , 10.1002/PON.3196